|
3
|
Ricci F, Carrassa L, Christodoulou MS, Passarella D, Michel B, Benhida R, Martinet N, Hunyadi A, Ioannou E, Roussis V, Musso L, Dallavalle S, Silvestri R, Westwood N, Mori M, Ingallina C, Botta B, Kavetsou E, Detsi A, Majer Z, Hudecz F, Bosze S, Kaminska B, Hansen TV, Bertrand P, Athanassopoulos CM, Damia G. A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells. Comb Chem High Throughput Screen 2019; 21:50-56. [PMID: 29366408 DOI: 10.2174/1386207321666180124093406] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 10/16/2017] [Accepted: 12/18/2017] [Indexed: 11/22/2022]
Abstract
BACKGROUND Epithelial ovarian cancer has a poor prognosis, mostly due to its late diagnosis and the development of drug resistance after a first platinum-based regimen. The presence of a specific population of "cancer stem cells" could be responsible of the relapse of the tumor and the development of resistance to therapy. For this reason, it would be important to specifically target this subpopulation of tumor cells in order to increase the response to therapy. METHOD We screened a chemical compound library assembled during the COST CM1106 action to search for compound classes active in targeting ovarian stem cells. We here report the results of the high-throughput screening assay in two ovarian cancer stem cells and the differentiated cells derived from them. RESULTS AND CONCLUSION Interestingly, there were compounds active only on stem cells, only on differentiated cells, and compounds active on both cell populations. Even if these data need to be validated in ad hoc dose response cytotoxic experiments, the ongoing analysis of the compound structures will open up to mechanistic drug studies to select compounds able to improve the prognosis of ovarian cancer patients.
Collapse
Affiliation(s)
- F Ricci
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
| | - L Carrassa
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
| | - M S Christodoulou
- Dipartimento di Chimica - Universita degli Studi di Milano - Via C. Golgi 19, 20133 Milan, Italy
| | - D Passarella
- Dipartimento di Chimica - Universita degli Studi di Milano - Via C. Golgi 19, 20133 Milan, Italy
| | - B Michel
- Universite Cote d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France
| | - R Benhida
- Universite Cote d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France
| | - N Martinet
- Universite Cote d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France
| | - A Hunyadi
- Institute of Pharmacognosy, University of Szeged, Eotvos str. 6, 6720 Szeged, Hungary and Interdisciplinary Centre for Natural Products, University of Szeged, Eotvos str. 6, 6720 Szeged, Hungary
| | - E Ioannou
- Department of Pharmacy, Section of Pharmacognosy and Chemistry of Natural Products, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
| | - V Roussis
- Department of Pharmacy, Section of Pharmacognosy and Chemistry of Natural Products, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
| | - L Musso
- Department of Food, Environmental and Nutritional Sciences, Universita degli Studi di Milano,Via Celoria 2, 20133 Milan, Italy
| | - S Dallavalle
- Department of Food, Environmental and Nutritional Sciences, Universita degli Studi di Milano,Via Celoria 2, 20133 Milan, Italy
| | - R Silvestri
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - N Westwood
- School of Chemistry and Biomedical Sciences ResearchComplex, University of St Andrews and EaStCHEM, St Andrews KY16, United Kingdom
| | - M Mori
- Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, viale Regina Elena 291, 00161 Rome, Italy
| | - C Ingallina
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - B Botta
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - E Kavetsou
- Department of Chemical Sciences, School of Chemical Engineering, National Technical University of Athens Iroon Politechniou 9, Zografou Campus, 15780 Athens, Greece
| | - A Detsi
- Department of Chemical Sciences, School of Chemical Engineering, National Technical University of Athens Iroon Politechniou 9, Zografou Campus, 15780 Athens, Greece
| | - Z Majer
- Department of Organic Chemistry, Eotvos Lorand University, H-1117 Budapest, Hungary
| | - F Hudecz
- Department of Organic Chemistry, Eotvos Lorand University, H-1117 Budapest, Hungary
| | - S Bosze
- Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eotvos Lorand University, H-1117 Budapest, Hungary
| | - B Kaminska
- Nencki Institute of Experimental Biology of Polish Acdemy of Sciences, Laboratory of Molecular Neurobiology, Neurobiology Center, 02-093 Warsaw, Pasteur 3 str, Poland
| | - T V Hansen
- School of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, N-0316 Oslo, Norway
| | - P Bertrand
- Institut de Chimie des Milieux et Materiaux de Poitiers, UMR CNRS 7285, 86000, Poitiers, France
| | | | - G Damia
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via Giuseppe La Masa 19, 20156 Milan, Italy
| |
Collapse
|